Breach-Valdez Journalism Prize in Mexico: A Look Back at the Migrant Plight

Two investigations into the plight of migrants won the support of the jury members—including AFP—for this award, which honours the memory of two Mexican journalists murdered in 2017.

Two investigations into the plight of migrants won the support of the jury members—including AFP—for this award, which honours the memory of two Mexican journalists murdered in 2017.
07/16/2025 10:47
Pluto Labs' 'Strategic Efficiency' AI Outperforms Google & Anthropic Models at a Fraction of the Cost  

In the global race to create an 'AI Scientist' capable of independent scientific discovery, Korean startup Pluto Labs is making significant waves. While tech giants like Google and Anthropic define competitive strength by sheer computing power, Pluto Labs introduces 'Scinapse AI,' a groundbreaking model that develops a more effective AI Scientist at just one-tenth of the usual computational cost, achieving overwhelming performance against top models in blind evaluations. This press release fea...

07/16/2025 10:45
Aude Gandon Appointed Chief Digital & Marketing Officer, The Estée Lauder Companies

The Estée Lauder Companies Inc. (NYSE: EL) announced today that Aude Gandon has been appointed Chief Digital & Marketing Officer (CDMO), effective August 1, 2025. Ms. Gandon will report directly to Stéphane de La Faverie, President and Chief Executive Officer, and will join the company's Executive Team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716106615/en/Aude Gandon, Chief Digital & Marketing Officer (CDMO), The E...

07/16/2025 11:00
Venture Global and Eni Announce 20-Year LNG Sales and Purchase Agreement

Today, Venture Global, Inc. (NYSE: VG) and Eni S.P.A. of Italy announced the execution of a new Sales and Purchase Agreement (SPA) for the purchase of 2 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from CP2 LNG, Venture Global’s third project, for 20 years. This deal marks Eni’s first ever long-term agreement with a U.S. LNG producer. To date, approximately 13.5 MTPA of CP2 Phase One has been sold, raising the total contracted capacity for all of Venture Global’s projects to 4...

07/16/2025 11:00
Veranex Unveils MedTech’s First Innovation CRO (iCRO)—Redefining R&D in a Capital‑Tight Market

Veranex, a global provider of product development and contract research services, today introduced the industry’s first Innovation CRO (iCRO)—an integrated development and research platform engineered to move medical devices and in-vitro diagnostics (IVDs) from concept to commercial success faster, with tighter budget control and a built-in path to payer adoption. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716366338/en/Verane...

Israël - Hamas: steady under fire

By Phil Chetwynd, AFP Global News Director

 

The Israel-Hamas war is one of the most complex and divisive stories AFP has covered. It touches historical fault lines that are generating visceral emotions in our societies, and in our newsrooms.

08/28/2025 06:00
Regula Recognized by Gartner in Magic Quadrant for Identity Verification

Regula, a global developer of identity verification (IDV) solutions and forensic devices, has been recognized in the 2025 Gartner® Magic Quadrant™ for Identity Verification research. For the company, this recognition marks the outstanding capabilities of Regula’s IDV software and its ability to meet the current market needs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250827049906/en/Regula's solutions provides smooth and compreh...

09/02/2025 08:30
Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars

Polpharma Biologics S.A. (“Polpharma Biologics”), specialized in the development and manufacturing of biosimilars, today announced that it has signed licensing agreements with MS Pharma, a leading biosimilar production and distribution company in the Middle East and North Africa (MENA) region, for the commercialization of its biosimilar candidates vedolizumab (PB016), ocrelizumab (PB018) and guselkumab (PB019) in the MENA region. Under the agreements, MS Pharma will be responsible for the reg...

07/29/2025 10:30
Compass Pathways Appoints Justin Gover to Board of Directors

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Justin Gover to its Board of Directors, effective immediately. Mr. Gover brings more than 25 years of leadership in the biopharmaceutical industry to this role. As part of this Board transition, Dr. Linda McGoldrick will retire from her position on the Board at the end of October after more than 5 years of servi...